Testimony to House E&C Health Subcommittee on Prescription Drug Pricing

Endocrine Society Statement for the Record Subcommittee on Health of the Committee on Energy and Commerce Negotiating a Better Deal: Legislation to Lower the Cost of Prescription Drugs May 4, 2021

"The Endocrine Society would like to thank Chairwoman Anna Eshoo (CA-18) and the members of the House Energy & Commerce Health Subcommittee for conducting this important hearing on legislation to lower the price of prescription drugs and reduce Americans’ out-of-pocket drug costs. The Society believes that Congress must act immediately to improve the affordability of and access to prescription drugs to improve the health of all Americans, including those living with diabetes and other chronic conditions. We also want to highlight the high price of insulin as an urgent issue that requires immediate attention. We applaud the efforts of Energy and Commerce Committee Chairman Frank Pallone Jr. (D-NJ), Ways and Means Committee Chairman Richard E. Neal (D-MA), and Education and Labor Committee Chairman Robert C. "Bobby" Scott (DVA) to reintroduce H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act. The reintroduction of this legislation is an important step forward in addressing this ongoing problem"

Read the Full Testimony

Policy Communications